At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ZJYL Jin Medical International Ltd.
Not Yet Opened 09-25 16:00:00 EDT
1.91
-0.09
-4.50%
盘后1.92
+0.01+0.36%
19:42 EDT
High2.01Low1.90Vol35.61K
Open1.94D1 Closing2.00Amplitude5.50%
Mkt Cap149.81MTradable Cap124.21MTotal Shares78.43M
T/O69.06KT/O Rate0.05%Tradable Shares65.03M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Jin Medical Closes Us$159.42 Million VIE Control Acquisition of Huaxia Qiying
Reuters  ·  09-25
Jin Medical Closes Us$159.42 Million VIE Control Acquisition of Huaxia Qiying
Jin Medical: Will Obtain Contractual Control Over, Right to Receive Substantially All Economic Benefits Of, Huaxia Qiying Through Vie Agreements
THOMSON REUTERS  ·  09-09
Jin Medical: Will Obtain Contractual Control Over, Right to Receive Substantially All Economic Benefits Of, Huaxia Qiying Through Vie Agreements
Jin Medical: After Close, Erhua Med Will Serve as Exclusive Provider of Business Support, Technical, Other Services to Chenglan Kangxu, Its Units
THOMSON REUTERS  ·  09-09
Jin Medical: After Close, Erhua Med Will Serve as Exclusive Provider of Business Support, Technical, Other Services to Chenglan Kangxu, Its Units
Jin Medical: Co, Erhua Med Will not Acquire Legal Title to Equity Interests of Chenglan Kangxu or Huaxia Qiying Solely as a Result of Vie Agreements
THOMSON REUTERS  ·  09-09
Jin Medical: Co, Erhua Med Will not Acquire Legal Title to Equity Interests of Chenglan Kangxu or Huaxia Qiying Solely as a Result of Vie Agreements
Jin Medical International Ltd: Agreement Provides for Aggregate Consideration of Us$159.4 Mln for Integrated Transaction
THOMSON REUTERS  ·  09-09
Jin Medical International Ltd: Agreement Provides for Aggregate Consideration of Us$159.4 Mln for Integrated Transaction
Jin Medical Agrees Us$159.42 Million VIE Control Deal for Huaxia Qiying Assets
Reuters  ·  09-09
Jin Medical Agrees Us$159.42 Million VIE Control Deal for Huaxia Qiying Assets
US Closing Bell | Megacaps resist mild pullback as Dow edges 0.1% lower
US Closing Bell  ·  08-11
US Closing Bell | Megacaps resist mild pullback as Dow edges 0.1% lower
Top Premarket Gainers
MT Newswires Live  ·  08-10
Top Premarket Gainers
Top Premarket Gainers
MT Newswires Live  ·  08-05
Top Premarket Gainers
Jin Medical International (ZJYL) Stock Soars Over 63% After Hours: Here's What You Need To Know
Benzinga Earnings  ·  08-05
Jin Medical International (ZJYL) Stock Soars Over 63% After Hours: Here's What You Need To Know
Jin Medical Turns to FY26 H1 Net Loss of USD 0.2 Million; Revenue Falls 9.7% to USD 8.9 Million
Reuters  ·  08-05
Jin Medical Turns to FY26 H1 Net Loss of USD 0.2 Million; Revenue Falls 9.7% to USD 8.9 Million
Jin Medical International Ltd. Reports First Half of Fiscal Year 2026 Financial Results
THOMSON REUTERS  ·  08-05
Jin Medical International Ltd. Reports First Half of Fiscal Year 2026 Financial Results
Press Release: JIN Medical International LTD. Reports First Half of Fiscal Year 2026 Financial Results
Dow Jones  ·  08-05
Press Release: JIN Medical International LTD. Reports First Half of Fiscal Year 2026 Financial Results
Jin Medical International Files Form 3 for Director Ning Xue
Reuters  ·  07-17
Jin Medical International Files Form 3 for Director Ning Xue
Jin Medical Names Ning Xue Independent Director, Replacing Jiayuan Tong
Reuters  ·  07-16
Jin Medical Names Ning Xue Independent Director, Replacing Jiayuan Tong
Jin Medical International Announces Shareholder Meetings
Reuters  ·  06-30
Jin Medical International Announces Shareholder Meetings
Jin Medical dismisses auditor Audit Alliance, hires Enrome as new accounting firm
Reuters  ·  06-04
Jin Medical dismisses auditor Audit Alliance, hires Enrome as new accounting firm
Jin Medical director Franklin Oliver St Clair Jr files initial beneficial ownership statement
Reuters  ·  05-06
Jin Medical director Franklin Oliver St Clair Jr files initial beneficial ownership statement
Jin Medical files Form 3 for director James Jiayuan Tong initial beneficial ownership statement
Reuters  ·  04-28
Jin Medical files Form 3 for director James Jiayuan Tong initial beneficial ownership statement
Jin Medical’s Guo Yanru files initial beneficial ownership statement as director
Reuters  ·  04-24
Jin Medical’s Guo Yanru files initial beneficial ownership statement as director

Introduction

Company Name.
Jin Medical International Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Issue price:
--